Gastrointestinal oncologist and health services researcher Ryan Nipp discusses new research about how muscle quality correlates with cancer outcomes.

by Ashley P. Taylor

At a patient advocate event, researchers discussed how to extend the benefits of immunotherapy to more people.

by Kevin McLaughlin

In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs?

by Anna Goshua

After her husband’s diagnosis with metastatic cancer, Miriam Díaz-Gilbert made it her goal to keep him moving.

by Miriam Díaz-Gilbert

Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.

by Anna Goshua

The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it's not clear the biomarker is valid across all cancer types.

by Anna Azvolinsky

For a small group of pancreatic cancer patients who were able to receive therapies targeting the molecular alterations in their tumors, these matched therapies were associated with longer life.

by Cheryl Platzman Weinstock

Cancer patients and their families share stories of fear, love and uncertainty as they find new ways to support each other.

by Jen Tota McGivney

Responding to the coronavirus, patient advocates and nonprofits expand existing outreach initiatives and launch new ones.

by Marci A. Landsmann

A father with metastatic kidney cancer embraces moments with his 3-year-old son while pondering how he'll be remembered.

by Adam P. Stern